Long acting contraceptives, when used correctly, can effectively prevent pregnancy and may bring additional health benefits, but there is also a certain risk of side effects. Long acting contraceptives mainly achieve contraception by inhibiting ovulation, altering the endometrial environment, and cervical mucus properties. Some types may improve dysmenorrhea and reduce the risk of ovarian cancer. The progesterone component in long-acting contraceptives can regulate menstrual cycles, reduce menstrual blood flow, and have therapeutic effects on patients with endometriosis or functional uterine bleeding. Compound preparations containing ethinylestradiol can maintain estrogen levels, prevent osteoporosis, and some studies have shown that use for more than 5 years may reduce the risk of ovarian cancer. The levonorgestrel intrauterine sustained-release system can act locally, reduce systemic hormone exposure, and is suitable for lactating women.
Some users may experience short-term reactions such as breakthrough bleeding and breast tenderness, and long-term use may increase the probability of venous thrombosis. The risk is more significant in women over 35 years old who smoke. A small number of people may experience emotional fluctuations and weight gain, and preparations containing androgenic active progestogens are more likely to cause acne. Patients with family history of breast cancer or severe migraine should be carefully evaluated.
Before use, a history of pregnancy and hormone dependent tumors should be ruled out. It is recommended to undergo annual breast and cervical examinations during medication. Sudden severe headache or chest pain requires immediate medical attention. Individualized plans can be discussed with doctors, such as choosing low-dose preparations for those who are sensitive to synthetic hormones, and considering progesterone monotherapy for those at risk of thrombosis. A healthy lifestyle such as supplementing folic acid and regular exercise can help reduce potential risks.
Comments (0)
Leave a Comment
No comments yet
Be the first to share your thoughts!